<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03490721</url>
  </required_header>
  <id_info>
    <org_study_id>Etude_maitrise_2018</org_study_id>
    <nct_id>NCT03490721</nct_id>
  </id_info>
  <brief_title>Effects of Clustering Care on the Physiological Stability of Preterm Infants.</brief_title>
  <official_title>Effects of Clustering Care on the Physiological Stability of Preterm Infants in a Neonatal Intensive Care Unit.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Montréal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Montréal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This crossover design experimental study aims to compare the physiological stability of
      premature newborns during and after a cluster of care compared to a period when they receive
      standard non clustered care at the neonatal unit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The cluster care will take place at the time of feeding of the premature infants. The
      intervention will start with a calm period of 20 minutes before the start of care (no
      manipulations will be allowed), the baby will then received the cluster care for 20 minutes
      and a quiet period of 30 minutes will follow after the cluster care.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 12, 2018</start_date>
  <completion_date type="Actual">May 30, 2019</completion_date>
  <primary_completion_date type="Actual">April 3, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Physiological stability (heart rate, respiratory rate and oxygen saturation)</measure>
    <time_frame>The physiological stability will be measured for 70 minutes.</time_frame>
    <description>The physiological stability will be measured with the SCRIP score. The Stability of the cardiorespiratory system in premature infants is a scale, in which a score of 0 means major physiological instability and a score of 6 means a physiological stability. For every single parameter there's three grades from severe instability (0 points) to minor instability (1 point) to perfect stability (2 points).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Premature Baby 26 to 32 Weeks</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clustering care for 20 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard care non clustered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clustering care</intervention_name>
    <description>During 20 minutes, preterm infants will receive a cluster care with 2 minutes of hand containment.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  between 26 to 31 6/7 weeks of gestation at birth

          -  more than 72 hours of life,

          -  receive a respiratory aid such as endotracheal tube, NIPPV (non invasive positive
             pressures ventilation), CPAP (continuous positive airway pressure) or nasal prongs
             with oxygen,

          -  are fed intravenously (IV) or by central venous catheter (CVC),

          -  one of the parents speaks and reads English or French,

          -  one of the parents is at least 18 years old to sign the consent.

        Exclusion Criteria:

          -  severely ill (necrotizing enterocolitis, septicemia),

          -  under respiratory assistance or on a high frequency mode,

          -  having a congenital or cardiac abnormality,

          -  requiring surgery,

          -  sedatives or opioids,

          -  diagnosed with grade II, III or IV intraventricular hemorrhage and / or hydrocephalus,

          -  have a device for invasive blood pressure,

          -  having an oxygen requirement of more than 30% to maintain oxygen saturation within the
             limits indicated by the NICU (neonatal intensive care unit).

          -  one of the parents is at least 18 years old to sign the consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>26 Weeks</minimum_age>
    <maximum_age>32 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marilyn Aita, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Université de Montréal</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jewish General Hospital</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H3T1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 23, 2018</study_first_submitted>
  <study_first_submitted_qc>April 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2018</study_first_posted>
  <last_update_submitted>January 14, 2020</last_update_submitted>
  <last_update_submitted_qc>January 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université de Montréal</investigator_affiliation>
    <investigator_full_name>Abril Nicole Fernandez Oviedo</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The results of this project could be made public in a journal or scientific congress.</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>The results of the study will be available when the study is finished.</ipd_time_frame>
    <ipd_access_criteria>The results will be published in a scientific journal.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

